Skip to main content

Table 1 Patient and lesion characteristics

From: Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion

 

Chocolate

n = 48

Conventional

n = 63

P

Patient characteristics

 Age, years

74 ± 8

74 ± 9

0.900

 Male, n (%)

36 (75)

46 (73)

0.814

 Body mass index, kg/m2

23.4 ± 4.2

23.2 ± 4.0

0.682

 Hypertension, n (%)

43 (90)

55 (87)

0.711

 Dyslipidemia, n (%)

28 (58)

32 (51)

0.430

 Diabetes mellitus, n (%)

31 (65)

41 (65)

0.957

 Chronic kidney disease, n (%)

31(65)

46(73)

0.340

 Hemodialysis, n (%)

16 (33)

27 (43)

0.308

 Smoker, n (%)

10 (21)

12 (19)

0.815

 Aspirin, n (%)

34 (71)

48 (76)

0.525

 Thienopyridine, n (%)

41 (85)

54 (86)

0.965

 Cilostazol, n (%)

12 (25)

10 (16)

0.232

 Prior Coronary artery disease, n (%)

16 (33)

28 (44)

0.236

 Prior peripheral artery disease, n (%)

22 (46)

31 (49)

0.725

 Prior cerebrovascular disease, n (%)

9 (19)

8 (13)

0.380

 Chronic limb-threatening ischemia, n (%)

10 (21)

19 (30)

0.268

Lesion characteristics

 Pre-ankle brachial index

0.70 ± 0.16

0.65 ± 0.17

0.094

 Post-ankle brachial index

0.93 ± 0.15

0.90 ± 0.19

0.744

 TASCII C/D, n (%)

20 (42)

33 (52)

0.263

 PACSS 3/4, n (%)

24 (50)

33 (52)

0.804

 include P2/3 lesion, n (%)

14 (29)

24 (38)

0.326

 CTO lesion, n (%)

11 (23)

22 (35)

0.170

 Lesion length, mm

134 ± 98

156 ± 96

0.116

 Vessel diameter, mm

4.7 ± 0.7

4.7 ± 0.9

0.468

 poor run off vessel, n (%)

14 (29)

24 (38)

0.326

  1. TASCII Trans-Atlantic Inter-Society Consensus II, PACSS Peripheral Arterial Calcium Scoring System, CTO Chronic total occlusion